Fesnak, Andrew D.
June, Carl H.
Levine, Bruce L.
Article History
First Online: 23 August 2016
Competing interests
: The University of Pennsylvania has entered into a partnership with Novartis for the development of chimeric antigen receptors. This partnership is managed in accordance with the University of Pennsylvania's conflict of interest policy. The authors are in compliance with this policy. B.L.L. and C.H.J.